Frost & Sullivan: European Hospitals Invest in Advanced Wound Care Products

- Innovative pricing strategies and product differentiation will be vital to increase profits

LONDON, May 21, 2014 /PRNewswire/ -- Along with enhanced awareness, the rising incidence of lifestyle diseases and an expanding, at-risk ageing population are pushing up the sales volumes of wound care and closure products across Western and Eastern Europe.

Hospitals are increasingly showing a preference for advanced wound care products that accelerate healing, as they realise that prolonged hospital stays and bed occupancy are a bigger cost burden than investment in these solutions. Patients too find advanced wound care products easier to use and more comfortable than traditional ones, giving a boost to the adoption rates.

New analysis from Frost & Sullivan, Western and Eastern European Wound Care and Wound Closure Market, finds that the market earned revenues of $4.41 billion in 2013 and estimates this to reach $6.41 billion in 2019.

"The increase in the volume of open surgical procedures is also fuelling the demand for wound closure products," said Frost & Sullivan Healthcare Research Analyst Parthasarathy Raghava. "Doctors across Western and Eastern Europe are particularly adopting new wound closure technologies that support scar-free surgery."

However, the lack of reimbursement for some advanced wound care and closure products is lowering market potential. The market is further pegged back by the proliferation of products from Asian markets and other regions. Moreover, the inability of hospitals to invest in costly technologies such as negative pressure wound therapy (NPWT) is forcing market participants to reassess their pricing strategies.

"Wound care product manufacturers have already started making NPWT and other active therapies more affordable by introducing rental models, portable solutions, and other cost-effective alternatives," noted Raghava. "They should continue finding ways to ensure that high-technology wound care solutions fit into current healthcare budgets."

In the meantime, wound closure product manufacturers will do well to launch products that have unique features and can deal with multiple types of wounds to stand out from the competition. They could also provide technical support and obtain feedback from hospitals regarding the quality and healing capabilities of their wound closure products.

For more information on this study, please email Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Western and Eastern European Wound Care and Wound Closure Market is part of the Advanced Medical Technologies (http://www.medtech.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: Wound Care and Wound Closure Market in India, Russia Joint Replacement and Trauma Fixation Devices Market, The Global Emerging Interventional Cardiac Devices Market, and Disinfection and Sterilisation Equipment Market Trends in Asia-Pacific. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: anna.zanchi@frost.com
http://www.frost.com